This document discusses leukocytosis, an increased number of white blood cells in the blood. It describes the different types of white blood cells and their normal functions. Leukocytosis can be caused by infections, inflammatory disorders, cancers, and medications. The main types of leukocytosis are neutrophilia, lymphocytosis, monocytosis, eosinophilia, and basophilia. Reactive leukocytosis is usually a response to infection or inflammation, while very high or persistent leukocytosis may indicate leukemia or other diseases.
This PPT covers leukocytosis and includes Types of leukocytosis-Neutrophilia, eosinophilia, basophilia, lymphocytosis and monocytosis, pathophysiology of leukocytosis, symptoms of leukocytosis and diagnosis of leukocytosis
Leukocyte is another name for white blood cell (WBC). These are the cells in your blood that help your body fight infections and some diseases.
When the number of white cells in your blood is higher than normal, it’s called leukocytosis. This usually happens because you’re sick, but sometimes it’s just a sign that your body is stressed.is a condition that affects all types of white blood cells. Other illnesses, such as neutrophilia, lymphocytosis, and granulocytosis, target specific types of white blood cells. Normal white blood cell counts are 4,300-10,800 white blood cells per microliter. Leukocyte or white blood cell levels are considered elevated when they are between 15,000-20,000 per microliter. The increased number of leukocytes can occur abnormally as a result of an infection.An abnormally large number of leukocytes, as observed in acute infections, inflammation, hemorrhage, and other conditions. A white blood cell count of 10,000/mm3 (or more) usually indicates leukocytosis Most examples of leukocytosis represent a disproportionate increase in the number of cells in the neutrophilic series, and the term is frequently used synonymously with the designation neutrophilia. Leukocytosis of 15,000-25,000/mm3 is frequently observed in various pathologic conditions, and values as high as 40,000 are not unusual; occasionally, as in some examples of leukemoid reactions, white blood cell counts may range up to 100,000/mm3.Leukocytosis is usually a response to an infection or inflammation, so it’s not a cause for alarm. However, it can be caused by serious diseases such as leukemia and other cancers, so it’s important that your doctor diagnose the cause of an increased WBC when it’s found. Leukocytosis associated with pregnancy or in response to exercise is normal and nothing to worry about.
This PPT covers leukocytosis and includes Types of leukocytosis-Neutrophilia, eosinophilia, basophilia, lymphocytosis and monocytosis, pathophysiology of leukocytosis, symptoms of leukocytosis and diagnosis of leukocytosis
Leukocyte is another name for white blood cell (WBC). These are the cells in your blood that help your body fight infections and some diseases.
When the number of white cells in your blood is higher than normal, it’s called leukocytosis. This usually happens because you’re sick, but sometimes it’s just a sign that your body is stressed.is a condition that affects all types of white blood cells. Other illnesses, such as neutrophilia, lymphocytosis, and granulocytosis, target specific types of white blood cells. Normal white blood cell counts are 4,300-10,800 white blood cells per microliter. Leukocyte or white blood cell levels are considered elevated when they are between 15,000-20,000 per microliter. The increased number of leukocytes can occur abnormally as a result of an infection.An abnormally large number of leukocytes, as observed in acute infections, inflammation, hemorrhage, and other conditions. A white blood cell count of 10,000/mm3 (or more) usually indicates leukocytosis Most examples of leukocytosis represent a disproportionate increase in the number of cells in the neutrophilic series, and the term is frequently used synonymously with the designation neutrophilia. Leukocytosis of 15,000-25,000/mm3 is frequently observed in various pathologic conditions, and values as high as 40,000 are not unusual; occasionally, as in some examples of leukemoid reactions, white blood cell counts may range up to 100,000/mm3.Leukocytosis is usually a response to an infection or inflammation, so it’s not a cause for alarm. However, it can be caused by serious diseases such as leukemia and other cancers, so it’s important that your doctor diagnose the cause of an increased WBC when it’s found. Leukocytosis associated with pregnancy or in response to exercise is normal and nothing to worry about.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.for more details please visit
www.indiandentalacademy.com
A presentation made by Dr Gauhar Mahmood Azeem on the interpretations of a simple CBC and the information it can give us, Various conditions which may cause derangement are mentioned,
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
3. “Blood Cells”
Erythrocytes: Red Blood Cells
(RBCs)
Platelets: Thrombocytes (clotting
cells)
Cell fragments from special cell in bone
marrow
Leukocytes: white blood cells
(WBCs) -
6. “Fancy Words for High and Low”
Cell Type Too High Too Low
Red Blood Cells (Erythrocytes)
Erythrocytosis or
Polycythemia
Anemia
Platelets (Thrombocytes)
Thrombocytosis or
Thrombocythemia
Thrombocytopenia
White Blood Cells (Leukocytes) Leukocytosis Leukopenia
Neutrophils Neutrophilia Neutropenia
Lymphocytes Lymphocytosis Lymphopenia
Eosinophils Eosinophilia ---
Monocytes Monocytosis ---
Basophils Basophilia ---
7. “Plasma”
Plasma is the liquid
component of blood
Comprised mostly of
water, but also
includes:
Protein (albumin,
globulin, fibrinogen)
Lipids (cholesterol,
triglycerides)
Dissolved salts and
minerals (sodium,
calcium, potassium)
Glucose
8. “Leukocytes”
White blood cells
Defend body through:
• the inflammatory process
• phagocytosis
• removal of cell debris
• immune reactions
9. White Blood Cell Types :
Granulocytes and Agranulocytes
Granulocytes – visible granules in
the cytoplasm
Granules contain:
• Enzymes
• Other biochemicals that serve as
signals and mediators of the
inflammatory response
10. Granulocyte cell types:
Neutrophils (60% to 70%) –
Phagocytes polymorphonuclear
leukocytes, Barely visible granules
in cytoplasm; three- to five-lobed
nucleus
Eosinophils (2% to 4%) – Large
red-orange granules, associated
with allergic response and parasitic
worms
Basophils (less than 1%) – Large,
abundant, violet granules granules -
Release heparin, histamine and
serotonin
11.
12.
13.
14. Agranulocytes
Granules too small to be visible
Monocytes (3% to 8%) – Largest WBC;
generally ovoid, kidney, or horseshoe-shaped
nucleus, become macrophages
Lymphocytes (25% to 33%) – B cells and
T cells = immune functions, Variable amounts
of bluish cytoplasm (scanty to abundant);
ovoid/round, uniform dark violet nucleus
17. • WBC’s originate in red bone marrow
from stem cells
• Granulocytes mature in the marrow and
have a lifespan of hours to days
• Agranulocytes finish maturing in blood,
or in other locations. Monocytes live
about 2 - 3 months, lymphocytes for
years
18. 18-18
Leukopoiesis
leaves
Lymphoblast
B prolymphocyte
B lymphocyte
T lymphocyte
NK cell
T prolymphocyte
NK prolymphocyte
Monoblast Promonocyte Monocyte
Basophil
Eosinophil
Neutrophil
Pluripotent
stem cell
Colony-forming
units (CFUs)
Precursor
cells
Mature
cells
Eosinophilic
myelocyte
Eosinophilic
promyelocyte
Eosinophilic
myeloblast
Eosinophilic
CFU
Basophilic
CFU
Neutrophilic
CFU
Monocytic
CFU
Lymphocytic
CFU
Basophilic
myeloblast
Neutrophilic
myeloblast
Neutrophilic
promyelocyte
Basophilic
promyelocyte
Basophilic
myelocyte
Neutrophilic
myelocyte
19. Production of WBC’s increases
in response to :
• Infection
• Presence of steroids
• Decreased reserve of
leukocyte pool in bone
marrow
20. “WBC Abnormalities”
Disorders of white blood cells can be classified into two
broad categories:
Proliferative disorders (Leukocytosis)
– increased numbers of WBC’s
May be a normal protective response to
physiological stressors
Or may signify a disease state – a
malignancy or hematologic disorder
Leukopenias – decreased numbers of
WBC’s – this is never normal
Increases the risk of infections
Agranulocytosis = granulocytopenia
21. “Leukopenia”
Leukemia—cancer of hemopoietic
tissue that usually produces an
extraordinary high number of
circulating leukocytes and their
precursors
Myeloid leukemia: uncontrolled
granulocyte production
Lymphoid leukemia: uncontrolled
lymphocyte or monocyte production
22. Leukopenia may be due to:
• High level radiation/toxin exposure
• Anaphylactic shock
• Autoimmune disease
• Chemotherapeutic agents
• Idiosyncratic drug reactions
• Splenomegaly
• Infections
• Mostly unknown
Causes
23. Types of Leukemia
All originate from the bone marrow
Aleukemic leukemia – no cancer cells
in circulation
Subleukemic leukemia – small
amounts of cancer cells in circulation
Leukemic leukemia – many cancer
cells in circulation
Maturity of leukemia
Acute leukemia – proliferation of
blasts, tends to be more severe
Chronic leukemia – proliferation of
more mature blood cells, tends to be
less severe
25. Signs and Symptoms
Insidious nonspecific onset
Pallor due to anemia
Febrile (fever) due to ineffective WBC
Petechiae (skin bruising) due to
thrombocytopenia
Bone pain
Hepatosplenomegaly
Lymphadenopathy
Fever, weight loss
Symptoms of cytopenias
26.
27.
28.
29. Pictures Of Blood
Normal human blood
White Cell Red Cell
Platelet
Blood with leukemia
BlastsRed Cell
Platelet
White Cell
32. Definition:
Leukocytosis refers to an increase in
the number of blood leukocytes
It is a common reaction to a variety of
inflammatory states and is sometimes
the first indication of neoplastic growth
of leukocytes
Usually affects a specific type of
leukocyte- neutrophil, basophil,
eosinophil, lymphocyte
33. Normal level is 4,400 to 10,000 WBC per mm3
This can result from many causes,
principally infections, inflammatory
disorders, and medications
Cancer and myeloproliferative disorders can
also cause high, sometimes extremely high,
WBC counts
Treatment is aimed at the underlying cause
Death may result from the underlying cause
such as severe infection or cancer
(leukemia)
34. Pathogenesis
The peripheral blood leukocyte count is
influenced by several factors, including:
1. The size of the myeloid (for granulocytes and
monocytes) and lymphoid (for lymphocytes)
precursor and storage cell pools in the bone
marrow, circulation, and peripheral tissues
2. Leukocyte homeostasis is maintained by
cytokines, growth factors, and adhesion
molecules through their effects on the
commitment, proliferation, differentiation, and
extravasation of leukocytes and their progenitors
35. 3. Other growth factors preferentially
stimulate other types of leukocytosis.
4. For example, IL-5 causes eosinophilia by
enhancing the growth, survival, and
differentiation of eosinophils, while IL-7
plays a central role in lymphopoiesis.
5. Such factors are differentially produced in
response to various pathogenic stimuli.
36. Pathogenesis
In most instances, it is not difficult to
distinguish reactive leukocytosis from
leukocytosis caused by flooding of the
peripheral blood by neoplastic white blood
cells (leukemia).
Uncertainties may arise in two settings:
1. Particularly in children, acute viral infections
can produce the appearance of activated
lymphocytes in the peripheral blood and
marrow that resemble neoplastic lymphoid
cells.
37. 2. At other times, particularly in inflammatory
states and severe chronic infections, many
immature granulocytes appear in the blood,
simulating a picture of myelogenous
leukemia (leukemoid reaction)
38. “Types of Leukocytosis”
There are five principal types of
leukocytosis :
Neutrophilia (the most common form)
Lymphocytosis
Monocytosis
Eosinophilia
Basophilia
40. Neutrophilic
leukocytosis
Acute bacterial infections, especially
those caused by pyogenic organisms;
sterile inflammation(myocardial
infarction, burns)
Eosinophilic
leukocytosis
(eosinophilia)
Allergic disorders such as asthma,
allergic skin diseases; parasitic
infestations; drug reactions; certain
malignancies (e.g., Hodgkin disease and
some non-Hodgkin lymphomas); collagen
vascular disorders and some vasculitides;
atheroembolic disease
41. Basophilic
leukocytosis
(basophilia)
Rare, often indicative of a
myeloproliferative disease (e.g.,
chronic myelogenous leukemia)
Monocytosis Chronic infections (e.g., tuberculosis),
bacterial endocarditis and malaria;
collagen vascular diseases (e.g.,
systemic lupus erythematosus) and
inflammatory bowel diseases (e.g.,
ulcerative colitis)
Lymphocytosis Accompanies monocytosis in many
disorders associated with chronic
immunologic stimulation (e.g.,
tuberculosis); viral infections (e.g.,
hepatitis)
43. Acute Inflammation (Left Shift)
Left shift indicates acute, intense inflammation
>1000/ul bands = left shift
300-1000/ul = mild left shift
Immature unsegmented neutrophils indicates a more
intense inflammation
Metamyelocytes
Myelocytes
promyelocytes
Peripheral myeloblasts often indicates leukemia
“Degenerative Left shift” = overwhelming inflammation
Normal pyramid of maturation is interrupted
Usually, the more mature forms are more plentiful
Segs > bands > meta > myelo > pro > blast
44. Chronic Inflammation
Monocytosis indicates inflammatory process is at
least 10 days old
Elevated globulins also indicate chronicity
Left shift rarely seen
WBC can be normal with significant chronic
inflammation
Other clues:
Recurring fever
Increased rouleaux formation
Vasculitis can develop with time
Normal leukogram does not rule out significant
infection or inflammation
45. Prognosis for Neutrophilia
Poor prognostic indicators :
Progressive degenerative left shift
WBC > 60,000/ul correlated with increased
risk of sudden death in dogs
Extremely high mature neutrophilia
“Leukemoid response”
Marked toxic changes in the neutrophils
Graded 1+ to 4+
Obvious infection without fever
Severe persistent lymphopenia
Sustained stress on the body
Magnitude of feline neutrophilic response is
less than canine
46. DDx Leukemoid Response
Internal abscess
Pyometra
Bacterial prostatitis
Pyothorax
Pancreatic/hepatic abscess
Neutrophil count often will continue to
accelerate for at least one week after
resolving abscess
IMHA (Immune mediated hemolytic anemia)
Neoplasia
Hepatozoon canis
47. Stress/Corticosteroid Response
<40,000/ul in the dog
<30,000/ul in the cat
Lymphopenia
Eosinopenia
Monocytosis
Mature neutrophilia
Increased hypersegmented segs
“right shift”
Onset within 4-13 hours
Resolves within 24 hours
57. Hypereosinophilic Syndrome (HES)
Primarily a disease of cats
Persistent eosinophilia
Organ infiltration with eosinophils
Bone marrow
Spleen
Liver
Lymph nodes (often mesenteric)
Gut
Skin
Clinical Signs
Diarrhea, vomiting
Anorexia, weight loss
Fever
Pruritus, lymphadenopathy
58. Abdominal masses are possible
Eventually causes organ failure and death
Difficult to distinguish from eosinophilic
leukemia (EL)
May be two forms of the same disease
More immature eos in circulation with EL
Treatment
No known effective treatment
Cortisteroids – immunosuppressive
Hydroxyurea
Alpha interferon
Gleevec (imatinib) has been used in
people
59. 5. Basophilia
Basophils can be difficult to identify
Mistaken for monocytes or eos
Parasites
Allergy
Mast Cell Tumor
Lipemia
Basophilic leukemia (very rare).
60. “References”
Fundamentals of Veterinary Clinical Pathology,
2nd Edition (Steven L. Stockham, Michael A.
Scott)
Practical Diagnostic Imaging for the Veterinary
Technician (Connie M. Han)
BSAVA Manual of Canine and Feline Clinical
Pathology
Diagnostic Cytology and Hematology of the
Dog and Cat (Rick L. Cowell)